4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-050592
EVP, General Counsel, Corp Sec sold 2,385 shares at $5.16 ($12,307)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP, General Counsel, Corp Sec | 2025-11-05 | Sale 10b5-1 | −2,385 | $5.16 | $12,307 | 78,210 | D |
| Open-market sales · 2,385 sh · avg $5.16 · $12,307 | |||||||
Loading xslF345X05/wk-form4_1762547269.xml…